SARS-CoV-2 IgG/IgM (Colloidal Gold) Kit is used for rapid and accurate screening of the COVID-19, which helps identify suspected patients and reduce false negative rate.
IgM is the first antibody to appear in the acute infection stage caused by pathogens such as SARS-CoV-2, and can normally be detected 3 days after the onset of symptoms, IgG is produced in the middle or later stage of the infection but provides long-term protection. In the latest Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 7), the SARS-CoV-2 IgG/IgM test is recommended as an aid in the diagnosis of the COVID-19.
IgM is the first antibody to appear in the acute infection stage caused by pathogens such as SARS-CoV-2, and can normally be detected 3 days after the onset of symptoms, IgG is produced in the middle or later stage of the infection but provides long-term protection. In the latest Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 7), the SARS-CoV-2 IgG/IgM test is recommended as an aid in the diagnosis of the COVID-19.
● 7 mins rapid test
● Various specimen types (whole blood/serum/plasma)
● Simultaneous detection of IgG and IgM
● Important complement to PCR detection in COVID-19 diagnosis
● 7 mins rapid test
● Various specimen types (whole blood/serum/plasma)
● Simultaneous detection of IgG and IgM
● Important complement to PCR detection in COVID-19 diagnosis
*Product images are for illustrative purposes only and may differ from the actual product. Goldsite Diagnostics Inc. reserves the right to change the packaging design at anytime.
